Albemarle Corporation (NYSE: ALB) took the market by surprise after it increased its projections for full-year 2022. Successful renegotiations of lithium contracts, post the first-quarter earnings release earlier this month, drove the revision. Shares of this $28.5-billion specialty chemical company grew 2.8% to close at $242.94 on Monday. The stock advanced an additional 2.5% in the extended trading session. Inside the Headlines Albemarle now projects 2022 revenues to be in the range of $5.8 billion to 6.2 billion, higher than the earlier projection of 5.2 billion to $5.6 billion.
https://www.tipranks.com/news/why-are-investors-excited-about-albemarle?utm_source=advfn.com&utm_medium=referral